J Obes Metab Syndr.  2021 Mar;30(1):74-75. 10.7570/jomes21006.

Response: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21)

Affiliations
  • 1Division of Endocrinology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea.
  • 2Division of Nephrology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea.
  • 3Konyang University Myunggok Medical Research Institute, Daejeon, Korea.

Full Text Links
  • JOMES
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error